Atlas Trials

Vismodegib and Gemcitabine Hydrochloride in Treating Patients With Advanced Pancreatic Cancer

Clinical trial NCT01195415 · COMPLETED

Trial details

NCT number
NCT01195415
Sponsor
National Cancer Institute (NCI)
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Recurrent Pancreatic CarcinomaStage IV Pancreatic Cancer
Start date
2010-06-01
Primary completion
2013-07-01
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.